BRANFORD, Conn., Jan. 3 /PRNewswire-FirstCall/ -- CAS Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has given clearance for the Company to market the new Model 750E Series Monitor. Coming just six months after the launch of the 750C Monitor, the new 750E incorporates either 3- or 5-lead ECG with impedance respiration along with the Company’s proprietary MAXNIBP(R) non-invasive blood pressure, a choice of Masimo Corporation SET(R) Pulse Oximetry or Nellcor(R) OxiMax(R) Pulse Oximetry, and Oridion Systems Ltd. Microstream(R) Capnography. The Company plans to launch this product within the first quarter of 2006.
Like the 750C, the 750E features “best-in-class” parameters that make a difference in patient care. The clinically proven Masimo SET Pulse Oximetry offers clinicians solutions to the problems of inaccuracy and false alarms associated with pulse oximetry due to patient motion, low perfusion and other challenging conditions. The Oridion Microstream Capnography provides a complete monitoring solution that can be used throughout patient care in emergency medical care, Emergency Department, ICU, OR, in-hospital transport, and procedural sedation. In addition, CAS’ own MAXNIBP technology has a proven reputation for fast, accurate blood pressure determinations for a range of patients from neonatal through adult under the most challenging situations.
With the addition of the 750E, the Company’s monitoring product line includes a full range of non-invasive measurement parameters for a wide variety of clinical applications, particularly in the areas of outpatient surgery, oral surgery and procedural sedation. “We are very pleased to expand our product line to include the measurement of ECG and impedance respiration”, stated Louis P. Scheps, President and CEO of CAS Medical Systems, Inc. “With the 750E, 750C and our well established 740 vital signs monitor, we can provide high quality, cost effective, extensive patient monitoring solutions to the clinician. We expect that this full line of products, with its advanced, best-in-class technologies, will provide new opportunities for growth and further expansion of our monitoring business.”
About CAS
Founded in 1984, CAS Medical Systems, Inc. is dedicated to the design and manufacture of innovative technologies and products vital to patient care in the most challenging clinical environments. Its current product lines include blood pressure measurement technology, vital signs monitoring equipment, apnea monitoring equipment and products for neonatal intensive care. With a reputation for the highest quality products available in the markets it serves, CAS products are used by clinicians worldwide.
For more information contact: CAS Medical Systems, Inc. 44 East Industrial Road Branford, CT 06405 (203) 488-6056 ir@casmed.com Financial Dynamics John Capodanno 212-850-5705 jcapodanno@fd-us.com
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, and other risks detailed in the Company’s Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms “anticipate,” “believe,” “estimate,” “expect,” “may,” “objective,” “plan,” “possible,” “potential,” “project,” “will” and similar expressions identify forward- looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise.
MAXNIBP is a registered trademark of CAS Medical Systems, Inc. Microstream is a registered trademark of Oridion Systems, Ltd. Masimo SET is a registered trademark of Masimo Corporation. Nellcor and OxiMax are registered trademarks of Tyco Healthcare, Inc.
CAS Medical Systems, Inc.
CONTACT: CAS Medical Systems, Inc., +1-203-488-6056, or ir@casmed.com; orJohn Capodanno of Financial Dynamics, +1-212-850-5705, orjcapodanno@fd-us.com
Web site: http://www.casmed.com//
